Dr. Weinberg is the Founder of ResQ Pharma and the inventor of LRT. He is currently a Professor of Anesthesiology at the
University of Illinois College of Medicine
at Chicago. He has authored over
100 peer-reviewed research articles.
Mr. Schupp is an accomplished attorney with extensive experience as outside counsel, in-house counsel and senior business management, leading efforts to transform business practices to improve process efficiency, strengthen operations and drive business production.
Chief Operating Officer
Mr. O’Keefe is a talented business development professional with over 14 years of sales, product development, and commercialization experience in the healthcare space. He is currently owner at Physician First Consultants, LLC, a distributor of specialty orthopedic implants and consultant to physician-preference medical device and pharmaceutical companies.
Mr. Tune has over 40 years of experience in the pharma/ biotech industry as a leader and board member. His diverse experiences range from building an $800M pharma services business at Baxter Healthcare to leading the turnaround and successful exit of a small biotech company on behalf of a Chicago-based private equity group.
LipidRescue® is an investigational drug; the safety and efficacy of the drug have not been approved or authorized by FDA.
LipidRescue® is a proposed proprietary name that is subject to FDA approval.
Website designed by JDW
Copyright © 2021 ResQ Pharma, Inc - All Rights Reserved.
Powered by GoDaddy